SCHEMBL6682434

SCHEMBL6682434

C[C@H]1O[C@@H](n2cc(I)c3cnc(N)nc32)[C@H](O)[C@@H]1O

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 19/20 0.59
▸ ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
5-Iodo,5'-Deoxytubercidin SCHEMBL6236636 0.74 ADK (1.00) ADK
5-Iodo,5'-Deoxytubercidin SCHEMBL8331903 0.74 ADK (1.00) ADK
SCHEMBL3827614 0.72 ADK (0.57) ADKADORA3
SCHEMBL3819268 0.72 ADK (0.57) ADKADORA3
SCHEMBL21413874 0.70 ADK (0.44) ADKADORA3
SCHEMBL8321626 0.70 ADK (0.76) ADK
SCHEMBL8323046 0.70 ADK (0.69) ADK
SCHEMBL1738203 0.69 CYP2C19 (0.45) ADKADORA3
SCHEMBL8330319 0.69 ADK (1.00) ADK
SCHEMBL6678245 0.69 ADK (1.00) ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832092-B1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2004-11-17 — — EP disclosed
EP-0832092-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-01 — — EP disclosed
WO-1996040706-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA-SICOR (US) 1996-12-19 — — WO disclosed
Send feedback